These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 23369448)

  • 21. Inhibiting PNP for the therapy of hyperuricemia in Lesch-Nyhan disease: Preliminary in vitro studies with analogues of immucillin-G.
    Jacomelli G; Baldini E; Mugnaini C; Micheli V; Bernardini G; Santucci A
    J Inherit Metab Dis; 2019 Jan; 42(1):178-185. PubMed ID: 30740729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Xanthine oxidase inhibition by febuxostat attenuates stress-induced hyperuricemia, glucose dysmetabolism, and prothrombotic state in mice.
    Yisireyili M; Hayashi M; Wu H; Uchida Y; Yamamoto K; Kikuchi R; Shoaib Hamrah M; Nakayama T; Wu Cheng X; Matsushita T; Nakamura S; Niwa T; Murohara T; Takeshita K
    Sci Rep; 2017 Apr; 7(1):1266. PubMed ID: 28455534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time to target uric acid to retard CKD progression.
    Kumagai T; Ota T; Tamura Y; Chang WX; Shibata S; Uchida S
    Clin Exp Nephrol; 2017 Apr; 21(2):182-192. PubMed ID: 27339448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperuricemia as a Risk Factor for Atrial Fibrillation Due to Soluble and Crystalized Uric Acid.
    Taufiq F; Li P; Miake J; Hisatome I
    Circ Rep; 2019 Nov; 1(11):469-473. PubMed ID: 33693087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dispelling dogma and misconceptions regarding the most pharmacologically targetable source of reactive species in inflammatory disease, xanthine oxidoreductase.
    Kelley EE
    Arch Toxicol; 2015 Aug; 89(8):1193-207. PubMed ID: 25995007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uric acid lowering therapy in cardiovascular diseases.
    Volterrani M; Iellamo F; Sposato B; Romeo F
    Int J Cardiol; 2016 Jun; 213():20-2. PubMed ID: 26386814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Linking uric acid metabolism to diabetic complications.
    Kushiyama A; Tanaka K; Hara S; Kawazu S
    World J Diabetes; 2014 Dec; 5(6):787-95. PubMed ID: 25512781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Xanthine oxidoreductase in atherosclerosis pathogenesis: not only oxidative stress.
    Battelli MG; Polito L; Bolognesi A
    Atherosclerosis; 2014 Dec; 237(2):562-7. PubMed ID: 25463089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Protective Effects of Increasing Serum Uric Acid Level on Development of Metabolic Syndrome.
    Yu TY; Jin SM; Jee JH; Bae JC; Lee MK; Kim JH
    Diabetes Metab J; 2019 Aug; 43(4):504-520. PubMed ID: 30877704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome.
    Gonçalves JP; Oliveira A; Severo M; Santos AC; Lopes C
    Endocrine; 2012 Jun; 41(3):450-7. PubMed ID: 22350659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The uric acid metabolism pathway as a therapeutic target in hyperuricemia related to metabolic syndrome.
    Simão AN; Lozovoy MA; Dichi I
    Expert Opin Ther Targets; 2012 Dec; 16(12):1175-87. PubMed ID: 23020656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study.
    Ogino K; Kato M; Furuse Y; Kinugasa Y; Ishida K; Osaki S; Kinugawa T; Igawa O; Hisatome I; Shigemasa C; Anker SD; Doehner W
    Circ Heart Fail; 2010 Jan; 3(1):73-81. PubMed ID: 19933411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Xanthine oxidoreductase activity is correlated with insulin resistance and subclinical inflammation in young humans.
    Washio KW; Kusunoki Y; Murase T; Nakamura T; Osugi K; Ohigashi M; Sukenaga T; Ochi F; Matsuo T; Katsuno T; Moriwaki Y; Yamamoto T; Namba M; Koyama H
    Metabolism; 2017 May; 70():51-56. PubMed ID: 28403945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ABCG2 expression and uric acid metabolism of the intestine in hyperuricemia model rat.
    Morimoto C; Tamura Y; Asakawa S; Kuribayashi-Okuma E; Nemoto Y; Li J; Murase T; Nakamura T; Hosoyamada M; Uchida S; Shibata S
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(5):744-759. PubMed ID: 31983315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease?
    Paschos P; Athyros VG; Tsimperidis A; Katsoula A; Grammatikos N; Giouleme O
    Curr Vasc Pharmacol; 2018; 16(3):269-275. PubMed ID: 28676018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Xanthine oxidoreductase: a journey from purine metabolism to cardiovascular excitation-contraction coupling.
    Agarwal A; Banerjee A; Banerjee UC
    Crit Rev Biotechnol; 2011 Sep; 31(3):264-80. PubMed ID: 21774633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High serum uric acid levels increase the risk of metabolic syndrome in elderly women: The PRO.V.A study.
    Zurlo A; Veronese N; Giantin V; Maselli M; Zambon S; Maggi S; Musacchio E; Toffanello ED; Sartori L; Perissinotto E; Crepaldi G; Manzato E; Sergi G
    Nutr Metab Cardiovasc Dis; 2016 Jan; 26(1):27-35. PubMed ID: 26643208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperuricemia contributes to the faster progression of diabetic kidney disease in type 2 diabetes mellitus.
    Bartáková V; Kuricová K; Pácal L; Nová Z; Dvořáková V; Švrčková M; Malúšková D; Svobodová I; Řehořová J; Svojanovský J; Olšovský J; Bělobrádková J; Kaňková K
    J Diabetes Complications; 2016; 30(7):1300-7. PubMed ID: 27324705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander?
    Tsouli SG; Liberopoulos EN; Mikhailidis DP; Athyros VG; Elisaf MS
    Metabolism; 2006 Oct; 55(10):1293-301. PubMed ID: 16979398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate.
    See LC; Kuo CF; Chuang FH; Li HY; Chen YM; Chen HW; Yu KH
    J Rheumatol; 2009 Aug; 36(8):1691-8. PubMed ID: 19531754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.